By Roberta Friedman, PhD. SAN FRANCISCO (Reuters Health) Oct 18 –  Follow-up of patients who received freeze-dried,

By Ori Twersky WASHINGTON (Reuters Health) Oct 18 – Director of the US Department of Health and

Cathy Tokarski Oct. 18, 2002 (San Diego) — Although many family physicians have sought a one-year extension

By Susan Comninos NEW YORK (Reuters Health) Oct 14 – MacroChem Corp. said on Friday that US

NEW YORK (Reuters Health) Oct 14 – Combination therapy with gemcitabine and epirubicin appears to be a

NEW YORK (Reuters Health) Oct 14 – In men with advanced prostate cancer, classifying bone scans according

מדענים אמריקאים גילו כי החומר הגנטי עובר שינוי משמעותי; גוף הגבר מתקשה לסנן תאי זרע פגומים, ולכן

For patients with prostate cancer who are to undergo radical prostatectomy, 3 months of neoadjuvant hormonal therapy

The polycomb group protein ‘enhancer of zeste’ homolog 2 (EZH2) is overexpressed in hormone-refractory metastatic prostate cancer,

Leflunomide reversed chronic renal allograft dysfunction in a prospective pilot study reported in the October issue of